NDC 71391-0130-05: Feminine Pain Relief Menthol, Unspecified Form 200 mg Patch, Pouch of 5
This is a package of 5 patches of Feminine Pain Relief Menthol, Unspecified Form 200 mg Patch from Unexo Life Sciences, Private Limited, no longer marketed (first marketed Jan 2019), no longer in the FDA NDC Directory. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 71391-130-05 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 71391 labeler · 130 product · 05 package
- Package marketed since
- Jan 19, 2019
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 7139113005 9
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
This is a topical patch containing 200 mg of menthol, an over-the-counter monograph product. Menthol is a cooling agent typically used to provide temporary relief of minor aches and pains. The patch form allows the menthol to be applied directly to the skin over the affected area. This product is marketed without individual FDA approval, under the established rules for over-the-counter topical pain relievers.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 71391-0130-05 You're viewing this Main listing | 5 PATCH in 1 POUCH | 2019-01-19 | — | Discontinued by firm |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Feminine Pain Relief 200 mgthis 71391-0130-05 | Unexo | 5 patches | — | — | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Unexo Life Sciences, Private Limited labeler code 71391
- Menthol 5% MENTHOL, UNSPECIFIED FORM 440 mg Patch NDC 71391-123-18
- Menthol 6.5% menthol, unspecified form 910 mg Patch NDC 71391-124-18
- Menthol 5% Hydrogel MENTHOL, UNSPECIFIED FORM 600 mg Patch NDC 71391-127-05
- Menthol 105 mg Patch NDC 71391-128-01
- Menthol Camphor Knee MENTHOL, UNSPECIFIED FORM and CAMPHOR (NATURAL) 308 mg; 308 mg Patch NDC 71391-139-05
- Menthol Camphor Micro MENTHOL, UNSPECIFIED FORM and CAMPHOR (NATURAL) 38.22 mg; 38.22 mg Patch NDC 71391-140-20
- Pain Relief 4% Lidocaine 344 mg Patch NDC 71391-151-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses For temporary relief of minor aches and pains in lower back and abdomen associated with cramps.
⏱️ Dosage and Administration ▾
Directions For use by Adults and Children 12 years of age and older Apply to the affected area no more than 2 times a day Dry skin completely at application area, before applying the patch Open pouch and remove patch Peel off protective film and apply sticky side to affected area If applied on hairy skin, remove gently using mild warm water Patch once used, cannot be re-pasted or reused Dispose properly after use
⚠️ Warnings ▾
Warnings For External Use Only. Do not use otherwise than as directed. Do Not Use On open wounds, cuts, eyes and face With a heating pad When using this product Avoid contact with eyes and mucous membranes Do not bandage tightly Ask Your Doctor Before Use if you have redness over the affected area have sensitive skin are pregnant or breast-feeding Stop Use and Ask Your Doctor If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days If abnormal skin irritation occurs after usage Keep Out of Reach of Children.
If swallowed, seek medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other Information Store at room temperature below 80°F (27°C)
🧪 Active Ingredient ▾
Active Ingredient Menthol 10%
🧪 Inactive Ingredients ▾
Inactive Ingredients Adhesive Plaster, Eucalyptus Oil
🎯 Purpose ▾
Purpose Topical Analgesic
📄 Do Not Use ▾
Do Not Use On open wounds, cuts, eyes and face With a heating pad
📄 Ask a Doctor Before Use If ▾
Ask Your Doctor Before Use if you have redness over the affected area have sensitive skin are pregnant or breast-feeding
📄 When Using This Product ▾
When using this product Avoid contact with eyes and mucous membranes Do not bandage tightly
📄 Stop Use and Ask a Doctor If ▾
Stop Use and Ask Your Doctor If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days If abnormal skin irritation occurs after usage
📄 Keep Out of Reach of Children ▾
Keep Out of Reach of Children. If swallowed, seek medical help or contact a Poison Control Center right away.
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 5 Patch Pouch PLEASE RESEAL AFTER OPENING NDC: 71391-130-05 unexo ® LIFE SCIENCES FEMININE PAIN RELIEF PATCH PACK OF 5 PATCHES SOOTHE PERIOD CRAMPS MEDICATED PATCH FAST ACTING APPLY FOR 8-12 HOURS Principal Display Panel - 5 Patch Pouch
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |